Incidence of Active Tuberculosis in Lung Cancer Patients Receiving Immune Checkpoint Inhibitors

被引：0
|
作者：
Fujita, K. [1 ]
机构：
[1] Natl Hosp Org Kyoto Med Ctr, Resp Med, Kyoto, Japan
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2021年 / 203卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A3918
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Thromboembolic events in patients with melanoma receiving immune checkpoint inhibitors: Incidence and risk factors
    van Dorst, D.
    Hofman, M. M.
    de Waal, R. M.
    Oomen-de Hoop, E.
    Joode, K. D.
    Bins, S.
    Koolen, S. L.
    Joosse, A.
    Versmissen, J.
    Van der Veldt, A. A. M.
    Mathijssen, R. H.
    ANNALS OF ONCOLOGY, 2023, 34 : S689 - S689
  • [42] Open questions between immune checkpoint inhibitors and tuberculosis incidence
    Wen, Ying
    Kang, Jing
    JOURNAL OF THORACIC DISEASE, 2024, 16 (08) : 5484 - 5486
  • [43] REAL-WORLD INCIDENCE AND IMPACT OF PNEUMONITIS IN LUNG CANCER PATIENTS TREATED WITH IMMUNE CHECKPOINT INHIBITORS
    Tiu, Bruce
    Zubiri, Leyre
    Iheke, James
    Pahalyants, Vartan
    Theodosakis, Nicholas
    Ugwu-Dike, Pearl
    Seo, Jayhyun
    Tang, Kimberly
    Sullivan, Ryan
    Mooradian, Meghan
    Semenov, Yevgeniy
    Reynolds, Kerry
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 : A841 - A841
  • [44] Incidence of Cardiotoxicity in Patients Treated for Non-Small Cell Lung Cancer with Immune Checkpoint Inhibitors
    Carpenter, I. N.
    Brice, K. B.
    Walker, D.
    Dumais, K.
    Alvarez, A. M.
    Cohen, N. S.
    Raez, L. E.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S629 - S629
  • [45] Predictive impact of antibiotics in patients with advanced non small-cell lung cancer receiving immune checkpoint inhibitors: Antibiotics immune checkpoint inhibitors in advanced NSCLC
    Schett, Anne
    Rothschild, Sacha I.
    Curioni-Fontecedro, Alessandra
    Kraehenbuehl, Stephan
    Frueh, Martin
    Schmid, S.
    Driessen, Christoph
    Joerger, Markus
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2020, 85 (01) : 121 - 131
  • [46] Risk of COVID-19 in Patients with Cancer Receiving Immune Checkpoint Inhibitors
    Klebanov, Nikolai
    Pahalyants, Vartan
    Murphy, William S.
    Theodosakis, Nicholas
    Zubiri, Leyre
    Klevens, R. Monina
    Kwatra, Shawn G.
    Lilly, Evelyn
    Reynolds, Kerry L.
    Semenov, Yevgeniy R.
    ONCOLOGIST, 2021, 26 (05): : E898 - E901
  • [47] Impact of opioid analgesics on survival in cancer patients receiving immune checkpoint inhibitors
    Kavgaci, Gozde
    Guven, Deniz Can
    Kaygusuz, Yunus
    Karaca, Ece
    Dizdar, Omer
    Kilickap, Saadettin
    Aksoy, Sercan
    Erman, Mustafa
    Yalcin, Suayib
    SUPPORTIVE CARE IN CANCER, 2024, 32 (07)
  • [48] Influenza vaccination in cancer patients receiving immune checkpoint inhibitors: A systematic review
    Spagnolo, Francesco
    Boutros, Andrea
    Croce, Elena
    Cecchi, Federica
    Arecco, Luca
    Tanda, Enrica
    Pronzato, Paolo
    Lambertini, Matteo
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2021, 51 (07)
  • [49] Safety of Inactivated Influenza Vaccine in Cancer Patients Receiving Immune Checkpoint Inhibitors
    Chong, Curtis R.
    Park, Vivian J.
    Cohen, Bevin
    Postow, Michael A.
    Wolchok, Jedd D.
    Kamboj, Mini
    CLINICAL INFECTIOUS DISEASES, 2020, 70 (02) : 193 - 199
  • [50] IMPACT OF COVID-19 ON CANCER PATIENTS RECEIVING IMMUNE CHECKPOINT INHIBITORS
    Tyan, Kevin
    Bui, Ai-Tram
    Giobbie-Hurder, Anita
    Klein, Isaac
    Manos, Michael
    Zubiri, Leyre
    Reynolds, Kerry
    Grover, Shilpa
    Weinhouse, Gerald
    Ott, Patrick
    LeBoeuf, Nicole
    Rahma, Osama
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 : A296 - A298
12345